Intragastric and intraperitoneal administration of Cry1Ac protoxin from Bacillus thuringiensis induces systemic and mucosal antibody responses in mice

Roberto I Vazquez-Padron, Leticia Moreno-Fierros, Leticia Neri-Bazán, Gustavo A. De la Riva, Rubén López-Revilla

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

The spore-forming soil bacterium Bacillus thuringiensis produces parasporal inclusion bodies composed by δ-endotoxins also known as Cry proteins, whose resistance to proteolysis, stability in highly alkaline pH and innocuity to vertebrates make them an interesting candidate to carrier of relevant epitopes in vaccines. The purpose of this study was to determine the mucosal and systemic immunogenicity in mice of Cry1Ac protoxin from B. thuringiensis HD73. Crystalline and soluble forms of the protoxin were administered by intraperitoneal or intragastric route and anti-Cry1Ac antibodies of the major isotypes were determined in serum and intestinal fluids. The two forms of Cry1Ac protoxin administered by intraperitoneal route induced a high systemic antibody response, however, only soluble Cry1Ac induced a mucosal response via intragastric. Serum antibody levels were higher than those induced by cholera toxin. Systemic immune responses were attained with doses of soluble Cry1Ac ranging from 0.1 to 100 μg by both routes, and the maximal effect was obtained with the highest doses. High anti-Cry1Ac IgG antibody levels were detected in the large and small intestine fluids from mice receiving the antigen via IP. These data indicate that Cry1Ac is a potent systemic and mucosal immunogen.

Original languageEnglish
Pages (from-to)1897-1912
Number of pages16
JournalLife Sciences
Volume64
Issue number21
DOIs
StatePublished - Apr 16 1999
Externally publishedYes

Fingerprint

Antibody Formation
Bacillus thuringiensis
Antibodies
Cholera Toxin
Large Intestine
Inclusion Bodies
Spores
Serum
Endotoxins
Proteolysis
Small Intestine
Vertebrates
Epitopes
Anti-Idiotypic Antibodies
Soil
Vaccines
Bacteria
Antigens
Fluids
Bacilli

Keywords

  • Antibody response
  • Bacillus thuringiensis
  • Cry1A proteins
  • Intestinal immunity

ASJC Scopus subject areas

  • Pharmacology

Cite this

Intragastric and intraperitoneal administration of Cry1Ac protoxin from Bacillus thuringiensis induces systemic and mucosal antibody responses in mice. / Vazquez-Padron, Roberto I; Moreno-Fierros, Leticia; Neri-Bazán, Leticia; De la Riva, Gustavo A.; López-Revilla, Rubén.

In: Life Sciences, Vol. 64, No. 21, 16.04.1999, p. 1897-1912.

Research output: Contribution to journalArticle

Vazquez-Padron, Roberto I ; Moreno-Fierros, Leticia ; Neri-Bazán, Leticia ; De la Riva, Gustavo A. ; López-Revilla, Rubén. / Intragastric and intraperitoneal administration of Cry1Ac protoxin from Bacillus thuringiensis induces systemic and mucosal antibody responses in mice. In: Life Sciences. 1999 ; Vol. 64, No. 21. pp. 1897-1912.
@article{9289990e638f4ce290472966d09ae5b8,
title = "Intragastric and intraperitoneal administration of Cry1Ac protoxin from Bacillus thuringiensis induces systemic and mucosal antibody responses in mice",
abstract = "The spore-forming soil bacterium Bacillus thuringiensis produces parasporal inclusion bodies composed by δ-endotoxins also known as Cry proteins, whose resistance to proteolysis, stability in highly alkaline pH and innocuity to vertebrates make them an interesting candidate to carrier of relevant epitopes in vaccines. The purpose of this study was to determine the mucosal and systemic immunogenicity in mice of Cry1Ac protoxin from B. thuringiensis HD73. Crystalline and soluble forms of the protoxin were administered by intraperitoneal or intragastric route and anti-Cry1Ac antibodies of the major isotypes were determined in serum and intestinal fluids. The two forms of Cry1Ac protoxin administered by intraperitoneal route induced a high systemic antibody response, however, only soluble Cry1Ac induced a mucosal response via intragastric. Serum antibody levels were higher than those induced by cholera toxin. Systemic immune responses were attained with doses of soluble Cry1Ac ranging from 0.1 to 100 μg by both routes, and the maximal effect was obtained with the highest doses. High anti-Cry1Ac IgG antibody levels were detected in the large and small intestine fluids from mice receiving the antigen via IP. These data indicate that Cry1Ac is a potent systemic and mucosal immunogen.",
keywords = "Antibody response, Bacillus thuringiensis, Cry1A proteins, Intestinal immunity",
author = "Vazquez-Padron, {Roberto I} and Leticia Moreno-Fierros and Leticia Neri-Baz{\'a}n and {De la Riva}, {Gustavo A.} and Rub{\'e}n L{\'o}pez-Revilla",
year = "1999",
month = "4",
day = "16",
doi = "10.1016/S0024-3205(99)00136-8",
language = "English",
volume = "64",
pages = "1897--1912",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "21",

}

TY - JOUR

T1 - Intragastric and intraperitoneal administration of Cry1Ac protoxin from Bacillus thuringiensis induces systemic and mucosal antibody responses in mice

AU - Vazquez-Padron, Roberto I

AU - Moreno-Fierros, Leticia

AU - Neri-Bazán, Leticia

AU - De la Riva, Gustavo A.

AU - López-Revilla, Rubén

PY - 1999/4/16

Y1 - 1999/4/16

N2 - The spore-forming soil bacterium Bacillus thuringiensis produces parasporal inclusion bodies composed by δ-endotoxins also known as Cry proteins, whose resistance to proteolysis, stability in highly alkaline pH and innocuity to vertebrates make them an interesting candidate to carrier of relevant epitopes in vaccines. The purpose of this study was to determine the mucosal and systemic immunogenicity in mice of Cry1Ac protoxin from B. thuringiensis HD73. Crystalline and soluble forms of the protoxin were administered by intraperitoneal or intragastric route and anti-Cry1Ac antibodies of the major isotypes were determined in serum and intestinal fluids. The two forms of Cry1Ac protoxin administered by intraperitoneal route induced a high systemic antibody response, however, only soluble Cry1Ac induced a mucosal response via intragastric. Serum antibody levels were higher than those induced by cholera toxin. Systemic immune responses were attained with doses of soluble Cry1Ac ranging from 0.1 to 100 μg by both routes, and the maximal effect was obtained with the highest doses. High anti-Cry1Ac IgG antibody levels were detected in the large and small intestine fluids from mice receiving the antigen via IP. These data indicate that Cry1Ac is a potent systemic and mucosal immunogen.

AB - The spore-forming soil bacterium Bacillus thuringiensis produces parasporal inclusion bodies composed by δ-endotoxins also known as Cry proteins, whose resistance to proteolysis, stability in highly alkaline pH and innocuity to vertebrates make them an interesting candidate to carrier of relevant epitopes in vaccines. The purpose of this study was to determine the mucosal and systemic immunogenicity in mice of Cry1Ac protoxin from B. thuringiensis HD73. Crystalline and soluble forms of the protoxin were administered by intraperitoneal or intragastric route and anti-Cry1Ac antibodies of the major isotypes were determined in serum and intestinal fluids. The two forms of Cry1Ac protoxin administered by intraperitoneal route induced a high systemic antibody response, however, only soluble Cry1Ac induced a mucosal response via intragastric. Serum antibody levels were higher than those induced by cholera toxin. Systemic immune responses were attained with doses of soluble Cry1Ac ranging from 0.1 to 100 μg by both routes, and the maximal effect was obtained with the highest doses. High anti-Cry1Ac IgG antibody levels were detected in the large and small intestine fluids from mice receiving the antigen via IP. These data indicate that Cry1Ac is a potent systemic and mucosal immunogen.

KW - Antibody response

KW - Bacillus thuringiensis

KW - Cry1A proteins

KW - Intestinal immunity

UR - http://www.scopus.com/inward/record.url?scp=0343253741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0343253741&partnerID=8YFLogxK

U2 - 10.1016/S0024-3205(99)00136-8

DO - 10.1016/S0024-3205(99)00136-8

M3 - Article

C2 - 10353588

AN - SCOPUS:0343253741

VL - 64

SP - 1897

EP - 1912

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 21

ER -